Tumour neoantigen mimicry by microbial species in cancer immunotherapy

Tumour neoantigens arising from cancer-specific mutations generate a molecular fingerprint that has a definite specificity for cancer. Although this fingerprint perfectly discriminates cancer from healthy somatic and germline cells, and is therefore therapeutically exploitable using immune checkpoin...

Descripción completa

Detalles Bibliográficos
Autores principales: Boesch, Maximilian, Baty, Florent, Rothschild, Sacha I., Tamm, Michael, Joerger, Markus, Früh, Martin, Brutsche, Martin H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329167/
https://www.ncbi.nlm.nih.gov/pubmed/33824481
http://dx.doi.org/10.1038/s41416-021-01365-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8329167/
https://www.ncbi.nlm.nih.gov/pubmed/33824481
http://dx.doi.org/10.1038/s41416-021-01365-2

Ejemplares similares